메뉴 건너뛰기




Volumn 17, Issue 2, 2008, Pages 51-58

Natriuretic peptides: Biochemical markers of anthracycline cardiac toxicity?

Author keywords

Anthracyclines; Cardiotoxicity; Natriuretic peptides

Indexed keywords

ANTHRACYCLINE; ATRIAL NATRIURETIC FACTOR; BIOCHEMICAL MARKER; BRAIN NATRIURETIC PEPTIDE; DAUNORUBICIN; DOXORUBICIN; DOXORUBICINOL; IDARUBICIN; NATRIURETIC FACTOR; NATRIURETIC PEPTIDE TYPE C; NATRIURETIC PEPTIDE TYPE D;

EID: 44849126207     PISSN: 09650407     EISSN: None     Source Type: Journal    
DOI: 10.3727/096504008784523621     Document Type: Review
Times cited : (16)

References (55)
  • 3
    • 0035398020 scopus 로고    scopus 로고
    • Late mortality experience in five-year survivors of childhood and adolescent cancer: The Childhood Cancer Survivors Study
    • Mertens, A.; Yasui, Y.; Neglia, J. P.; Potter, J. D.; Nesbit, M. E.; Ruccione, K.; Smithson, W. A.; Robison, L. L. Late mortality experience in five-year survivors of childhood and adolescent cancer: The Childhood Cancer Survivors Study. J. Clin. Oncol. 19:3163-3172; 2001.
    • (2001) J. Clin. Oncol , vol.19 , pp. 3163-3172
    • Mertens, A.1    Yasui, Y.2    Neglia, J.P.3    Potter, J.D.4    Nesbit, M.E.5    Ruccione, K.6    Smithson, W.A.7    Robison, L.L.8
  • 4
    • 0032563825 scopus 로고    scopus 로고
    • Doxorubicin-induced cardiomyopthy
    • Singal, P. K.; Iliskovic, N. Doxorubicin-induced cardiomyopthy. N. Engl. J. Med. 339:900-905; 1998.
    • (1998) N. Engl. J. Med , vol.339 , pp. 900-905
    • Singal, P.K.1    Iliskovic, N.2
  • 6
    • 0025637635 scopus 로고
    • The impact of childhood cancer in the United States and the world
    • Bleyer, W. A. The impact of childhood cancer in the United States and the world. Cancer J. Clin. 40:354-367; 1990.
    • (1990) Cancer J. Clin , vol.40 , pp. 354-367
    • Bleyer, W.A.1
  • 7
    • 0026714331 scopus 로고
    • The anthracyclines: Will we ever find a better doxorubicine?
    • Weiss, R. B. The anthracyclines: Will we ever find a better doxorubicine? Semin. Oncol. 19:670-686; 1992.
    • (1992) Semin. Oncol , vol.19 , pp. 670-686
    • Weiss, R.B.1
  • 8
    • 33747852312 scopus 로고    scopus 로고
    • Anthracyclines in early breast cancer
    • Wilson, K. S. Anthracyclines in early breast cancer. N. Engl. J. Med. 355:845; 2006.
    • (2006) N. Engl. J. Med , vol.355 , pp. 845
    • Wilson, K.S.1
  • 9
    • 0037102148 scopus 로고    scopus 로고
    • Doxorubicin treatment in vivo causes cytochrome C release and cardiomyocyte apoptosis, as well as increased mitochondrial efficiency, superoxide dismutase activity, and Bcl-2:Bax ratio
    • Childs, A. C.; Phaneuf, S. L.; Dirks, A. J.; Phillips, T.; Leeuwenburgh, C. Doxorubicin treatment in vivo causes cytochrome C release and cardiomyocyte apoptosis, as well as increased mitochondrial efficiency, superoxide dismutase activity, and Bcl-2:Bax ratio. Cancer Res. 62:4592-4598; 2002.
    • (2002) Cancer Res , vol.62 , pp. 4592-4598
    • Childs, A.C.1    Phaneuf, S.L.2    Dirks, A.J.3    Phillips, T.4    Leeuwenburgh, C.5
  • 10
    • 0002670847 scopus 로고
    • Pathophysiology of anthracyclines cardiotoxicity
    • Bricker, J. T, Green, D. M, D'Angio, G. J, eds, New York: Wiley-Liss;
    • Herman, E. H.; Ferrans, V. J. Pathophysiology of anthracyclines cardiotoxicity. In: Bricker, J. T.; Green, D. M.; D'Angio, G. J., eds. Cardiac toxicity after treatment for childhood cancer. New York: Wiley-Liss; 1993:25-34.
    • (1993) Cardiac toxicity after treatment for childhood cancer , pp. 25-34
    • Herman, E.H.1    Ferrans, V.J.2
  • 11
    • 33745008604 scopus 로고    scopus 로고
    • Pathogenesis of cardiotoxicity induced by anthracyclines
    • Elliott, P. Pathogenesis of cardiotoxicity induced by anthracyclines. Semin. Oncol. 33:S2-S7; 2006.
    • (2006) Semin. Oncol , vol.33
    • Elliott, P.1
  • 12
    • 2642566088 scopus 로고    scopus 로고
    • Anthracyclines: Molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity
    • Minotti, G.; Menna, P.; Salvatorelli, E.; Cairo, G.; Gianni, L. Anthracyclines: Molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharmacol. Rev. 56:185-229; 2004.
    • (2004) Pharmacol. Rev , vol.56 , pp. 185-229
    • Minotti, G.1    Menna, P.2    Salvatorelli, E.3    Cairo, G.4    Gianni, L.5
  • 13
    • 0037311110 scopus 로고    scopus 로고
    • Anthracycline-induced suppression of GATA-4 transcription factor: Implication in the regulation of cardiac myocyte apoptosis
    • Kim, Y.; Ma, A. G.; Kitta, K.; Fitch, S. N.; Ikeda, T.; Ihara, Y.; Simon, A. R.; Evans, T.; Suzuki, Y. J. Anthracycline-induced suppression of GATA-4 transcription factor: Implication in the regulation of cardiac myocyte apoptosis. Mol. Pharmacol. 63:368-377; 2003.
    • (2003) Mol. Pharmacol , vol.63 , pp. 368-377
    • Kim, Y.1    Ma, A.G.2    Kitta, K.3    Fitch, S.N.4    Ikeda, T.5    Ihara, Y.6    Simon, A.R.7    Evans, T.8    Suzuki, Y.J.9
  • 14
    • 0033965484 scopus 로고    scopus 로고
    • Mechanisms of doxorubicin-induced inhibition of sarcoplasmic reticulum CaATPase gene transcription
    • Arai, M.; Yoguchi, A.; Takizawa, T. Mechanisms of doxorubicin-induced inhibition of sarcoplasmic reticulum CaATPase gene transcription. Mol. Med. 86:8-14; 2000.
    • (2000) Mol. Med , vol.86 , pp. 8-14
    • Arai, M.1    Yoguchi, A.2    Takizawa, T.3
  • 15
    • 0032795759 scopus 로고    scopus 로고
    • Cardiotoxicity of cancer therapy
    • Tolba, K.; Deliargyris, E. N. Cardiotoxicity of cancer therapy. Cancer Invest. 17:408-422; 1999.
    • (1999) Cancer Invest , vol.17 , pp. 408-422
    • Tolba, K.1    Deliargyris, E.N.2
  • 16
    • 0035479423 scopus 로고    scopus 로고
    • Nuclear magnetic resonance study of doxorubicin binding to cardiolipin containing magnetically oriented phospholipid bilayers
    • Parker, M. A.; King, V.; Howard, K. P. Nuclear magnetic resonance study of doxorubicin binding to cardiolipin containing magnetically oriented phospholipid bilayers. Biochim. Biophys. Acta 1514:206-216; 2001.
    • (2001) Biochim. Biophys. Acta , vol.1514 , pp. 206-216
    • Parker, M.A.1    King, V.2    Howard, K.P.3
  • 17
    • 0024208168 scopus 로고
    • Cardiac matrix alterations induced by adriamycin
    • Caulfield, J. B.; Bittner, V. Cardiac matrix alterations induced by adriamycin. Am. J. Pathol. 133:298-230; 1988.
    • (1988) Am. J. Pathol , vol.133 , pp. 298-230
    • Caulfield, J.B.1    Bittner, V.2
  • 18
    • 0035209431 scopus 로고    scopus 로고
    • Frequency-domain analysis of the QRS complex after treatment of childhood cancer with anthracycline cytostatics
    • Mladosievicova, B.; Foltinova, A.; Luptak, I.; Petrasova, H.; Hulin, I. Frequency-domain analysis of the QRS complex after treatment of childhood cancer with anthracycline cytostatics. Pediatr. Cardiol. 22:478-482; 2001.
    • (2001) Pediatr. Cardiol , vol.22 , pp. 478-482
    • Mladosievicova, B.1    Foltinova, A.2    Luptak, I.3    Petrasova, H.4    Hulin, I.5
  • 19
    • 33644633955 scopus 로고    scopus 로고
    • The anticancer drug, doxorubicin, causes oxidant stress-induced endothelial dysfunction
    • Wolf, M. B.; Baynes, J. W. The anticancer drug, doxorubicin, causes oxidant stress-induced endothelial dysfunction. Biochim. Biophys. Acta 1760:267-271; 2006.
    • (2006) Biochim. Biophys. Acta , vol.1760 , pp. 267-271
    • Wolf, M.B.1    Baynes, J.W.2
  • 20
    • 33744966574 scopus 로고    scopus 로고
    • Anthracycline-induced cardiotoxicity in adult hematologic malignancies
    • Johnson, S. A. Anthracycline-induced cardiotoxicity in adult hematologic malignancies. Semin. Oncol. 33:S22-S27; 2006.
    • (2006) Semin. Oncol , vol.33
    • Johnson, S.A.1
  • 21
    • 34548331601 scopus 로고    scopus 로고
    • Anthracycline cardiotoxicity in long-term survivors of childhood cancer
    • Scully, R. E.; Lipshultz, S. E. Anthracycline cardiotoxicity in long-term survivors of childhood cancer. Cardiovasc. Toxicol. 7:122-128; 2007.
    • (2007) Cardiovasc. Toxicol , vol.7 , pp. 122-128
    • Scully, R.E.1    Lipshultz, S.E.2
  • 23
    • 33845507311 scopus 로고    scopus 로고
    • Biochemical markers for predicting chemotherapy induced cardiotoxicity: Systematic review of the literature and recommendations for use
    • Dolci, A.; Dominici, R.; Cardinale, D.; Sandri, M. T.; Panteghini, M. Biochemical markers for predicting chemotherapy induced cardiotoxicity: Systematic review of the literature and recommendations for use. J. Ital. Cardiol. 7:604-611; 2006.
    • (2006) J. Ital. Cardiol , vol.7 , pp. 604-611
    • Dolci, A.1    Dominici, R.2    Cardinale, D.3    Sandri, M.T.4    Panteghini, M.5
  • 25
    • 0031834174 scopus 로고    scopus 로고
    • Natriuretic peptides: Physiology, therapeutic potential, and risk stratification in ischemic heart disease
    • Stein, B. C.; Levin, R. I. Natriuretic peptides: Physiology, therapeutic potential, and risk stratification in ischemic heart disease. Am. Heart. J. 135:914-923; 1998.
    • (1998) Am. Heart. J , vol.135 , pp. 914-923
    • Stein, B.C.1    Levin, R.I.2
  • 26
    • 27444437297 scopus 로고    scopus 로고
    • Clinical usefulness of B-type natriuretic peptide measurement: Present and future perspectives
    • Bettencourt, P. M. Clinical usefulness of B-type natriuretic peptide measurement: Present and future perspectives. Heart 91:1489-1494; 2005.
    • (2005) Heart , vol.91 , pp. 1489-1494
    • Bettencourt, P.M.1
  • 28
    • 1342312430 scopus 로고    scopus 로고
    • Vanderheyde, M.; Bartunek, J.; Goethals, M. Brain and other natriuretic peptides: Molecular aspects. Eur. J. Heart Fail. 6:261-268; 2004.
    • Vanderheyde, M.; Bartunek, J.; Goethals, M. Brain and other natriuretic peptides: Molecular aspects. Eur. J. Heart Fail. 6:261-268; 2004.
  • 29
    • 0030013030 scopus 로고    scopus 로고
    • New insight into the cardiac natriuretic peptides
    • Bonow, R. O. New insight into the cardiac natriuretic peptides. Circulation 93:1946-1950; 1996.
    • (1996) Circulation , vol.93 , pp. 1946-1950
    • Bonow, R.O.1
  • 30
    • 0036089912 scopus 로고    scopus 로고
    • Role of cardiac natriuretic peptide testing in heart failure
    • Mair, J. Role of cardiac natriuretic peptide testing in heart failure. Clin. Chem. 48:977-978; 2002.
    • (2002) Clin. Chem , vol.48 , pp. 977-978
    • Mair, J.1
  • 31
    • 33645791709 scopus 로고    scopus 로고
    • Clinical relevance of biological variation: The lesson of brain natriuretic peptide (BNP) and NT-proBNP assay
    • Clerico, A.; Zucchelli, G. C.; Pilo, A.; Passino, C.; Emdin, M. Clinical relevance of biological variation: The lesson of brain natriuretic peptide (BNP) and NT-proBNP assay. Clin. Chem. Lab. Med. 44:366-378; 2006.
    • (2006) Clin. Chem. Lab. Med , vol.44 , pp. 366-378
    • Clerico, A.1    Zucchelli, G.C.2    Pilo, A.3    Passino, C.4    Emdin, M.5
  • 33
    • 14844333579 scopus 로고    scopus 로고
    • B-type natriuretic peptide levels are not a surrogate marker for invasive hemodynamics during management of patients with severe heart failure
    • O'Neill, J. O.; Bott-Silverman, C. E.; McRae, 3rd, A. T.; Troughton, R. W.; Ng, K.; Starling, R. C.; Young, J. B. B-type natriuretic peptide levels are not a surrogate marker for invasive hemodynamics during management of patients with severe heart failure. Am. Heart J. 149:363-369; 2005
    • (2005) Am. Heart J , vol.149 , pp. 363-369
    • O'Neill, J.O.1    Bott-Silverman, C.E.2    McRae 3rd, A.T.3    Troughton, R.W.4    Ng, K.5    Starling, R.C.6    Young, J.B.7
  • 35
    • 0026570936 scopus 로고
    • Atrial natriuretic peptide as a marker for doxorubicin induced cardiotoxic effects
    • Bauch, M.; Ester, A.; Kimura, B.; Victorica, B. E.; Kedar, A.; Phillips, M. I. Atrial natriuretic peptide as a marker for doxorubicin induced cardiotoxic effects. Cancer 69:1492-1497; 1992.
    • (1992) Cancer , vol.69 , pp. 1492-1497
    • Bauch, M.1    Ester, A.2    Kimura, B.3    Victorica, B.E.4    Kedar, A.5    Phillips, M.I.6
  • 36
    • 0031856391 scopus 로고    scopus 로고
    • Serum N-terminal atrial natriuretic peptide (NTANP) in the cardiac follow-up in children with cancer
    • Tikanoja, T.; Riikonen, P.; Perkkio, M.; Helenius, T. Serum N-terminal atrial natriuretic peptide (NTANP) in the cardiac follow-up in children with cancer. Med. Pediatr. Oncol. 31:73-78; 1998.
    • (1998) Med. Pediatr. Oncol , vol.31 , pp. 73-78
    • Tikanoja, T.1    Riikonen, P.2    Perkkio, M.3    Helenius, T.4
  • 37
    • 0037811735 scopus 로고    scopus 로고
    • Long-term prospective follow-up study of cardiac function after cardiotoxic therapy for malignancy in children
    • Poutanen, T.; Tikanoja, T.; Riikonen, P.; Silvast, A.; Perkkio, M. Long-term prospective follow-up study of cardiac function after cardiotoxic therapy for malignancy in children. J. Clin. Oncol. 21:2349-2356; 2003.
    • (2003) J. Clin. Oncol , vol.21 , pp. 2349-2356
    • Poutanen, T.1    Tikanoja, T.2    Riikonen, P.3    Silvast, A.4    Perkkio, M.5
  • 38
    • 0034964104 scopus 로고    scopus 로고
    • Plasma levels of natriuretic peptides in relation to doxorubicin-induced cardiotoxicity and cardiac function in children with cancer
    • Hayakawa, H.; Komada, Y.; Hirayama, M.; Hori, H.; Ito, M.; Sakurai, M. Plasma levels of natriuretic peptides in relation to doxorubicin-induced cardiotoxicity and cardiac function in children with cancer. Med. Pediatr. Oncol. 37:4-9; 2001.
    • (2001) Med. Pediatr. Oncol , vol.37 , pp. 4-9
    • Hayakawa, H.1    Komada, Y.2    Hirayama, M.3    Hori, H.4    Ito, M.5    Sakurai, M.6
  • 39
    • 24744439974 scopus 로고    scopus 로고
    • Plasma concentrations of NT-pro-BNP and cardiac troponin-I in relation to doxorubicin-induced cardiomyopathy and cardiac function in childhood malignancy
    • Soker, M.; Kervancioglu, M. Plasma concentrations of NT-pro-BNP and cardiac troponin-I in relation to doxorubicin-induced cardiomyopathy and cardiac function in childhood malignancy. Saudi Med. J. 26:1197-1202; 2005.
    • (2005) Saudi Med. J , vol.26 , pp. 1197-1202
    • Soker, M.1    Kervancioglu, M.2
  • 40
    • 44849141771 scopus 로고    scopus 로고
    • Accelerated atherosclerosis contributes to elevated global risk for premature symptomatic cardiovascular disease in survivors of childhood cancer
    • Abstract No
    • Lipshultz, S. E.; Hinkle, A. S.; French, C. A.; Kozlowski, A. M.; Constine, L. S. Accelerated atherosclerosis contributes to elevated global risk for premature symptomatic cardiovascular disease in survivors of childhood cancer. Abstract No: 3203, ASCO Annual Meeting; 2003.
    • (2003) 3203, ASCO Annual Meeting
    • Lipshultz, S.E.1    Hinkle, A.S.2    French, C.A.3    Kozlowski, A.M.4    Constine, L.S.5
  • 41
    • 33644685056 scopus 로고    scopus 로고
    • Correlation of plasma N-terminal probrain natriuretic peptide levels with left ventricle mass in children treated with anthracyclines
    • Germanakis, I.; Kalmanti, M.; Parthenakis, F.; Nikitovic, D.; Stiakaki, E.; Patrianakos, A.; Vardas, P. E. Correlation of plasma N-terminal probrain natriuretic peptide levels with left ventricle mass in children treated with anthracyclines. Int. J. Cardiol. 108:212-215; 2006.
    • (2006) Int. J. Cardiol , vol.108 , pp. 212-215
    • Germanakis, I.1    Kalmanti, M.2    Parthenakis, F.3    Nikitovic, D.4    Stiakaki, E.5    Patrianakos, A.6    Vardas, P.E.7
  • 43
    • 0032909472 scopus 로고    scopus 로고
    • Natriuretic peptides as markers of cardiotoxicity during doxorubicin treatment for non-Hodgkin's lymphoma
    • Nousiainen, T.; Jantunen, E.; Vanninen, E.; Remes, J.; Vuolteenaho, O.; Hartikainen, J. Natriuretic peptides as markers of cardiotoxicity during doxorubicin treatment for non-Hodgkin's lymphoma. Eur. J. Haematol. 62:135-141; 1999.
    • (1999) Eur. J. Haematol , vol.62 , pp. 135-141
    • Nousiainen, T.1    Jantunen, E.2    Vanninen, E.3    Remes, J.4    Vuolteenaho, O.5    Hartikainen, J.6
  • 44
    • 0035212366 scopus 로고    scopus 로고
    • Neuroendocrine changes during the evolution of doxorubicin-induced left ventricular dysfunction in adult lymphoma patients
    • Nousiainen, T.; Vanninen, E.; Jantunen, E.; Remes, J.; Ritanen, E.; Vuolteenaho, O.; Hartikainen, J. Neuroendocrine changes during the evolution of doxorubicin-induced left ventricular dysfunction in adult lymphoma patients. Clin. Sci. (Lond.) 101:601-607; 2001.
    • (2001) Clin. Sci. (Lond.) , vol.101 , pp. 601-607
    • Nousiainen, T.1    Vanninen, E.2    Jantunen, E.3    Remes, J.4    Ritanen, E.5    Vuolteenaho, O.6    Hartikainen, J.7
  • 49
    • 33745746827 scopus 로고    scopus 로고
    • Comparison of plasmatic levels of B-natriuretic peptide with echocardiographicindicators of left ventricle function after doxorubicin therapy
    • Elbl, L.; Vasova, I.; Navratil, M.; Vorlicek, J.; Malaskova, L.; Spinar, J. Comparison of plasmatic levels of B-natriuretic peptide with echocardiographicindicators of left ventricle function after doxorubicin therapy. Vnitr. Lek. 52:563-570; 2006.
    • (2006) Vnitr. Lek , vol.52 , pp. 563-570
    • Elbl, L.1    Vasova, I.2    Navratil, M.3    Vorlicek, J.4    Malaskova, L.5    Spinar, J.6
  • 53
    • 17644388763 scopus 로고    scopus 로고
    • Drug-induced cardiotoxicity studied by longitudinal B-type natriuretic peptide assays and radionuclide ventriculography
    • Pichon, M. F.; Cvitkovic, F.; Hacene, K.; van der Graaf, W. T.; Sleijfer, D. T.; van Veldhuisen, D. J.; Gietema, J. A. Drug-induced cardiotoxicity studied by longitudinal B-type natriuretic peptide assays and radionuclide ventriculography. In Vivo 19:567-576; 2005.
    • (2005) In Vivo , vol.19 , pp. 567-576
    • Pichon, M.F.1    Cvitkovic, F.2    Hacene, K.3    van der Graaf, W.T.4    Sleijfer, D.T.5    van Veldhuisen, D.J.6    Gietema, J.A.7
  • 54
    • 33750303897 scopus 로고    scopus 로고
    • Serial testing of B-type natriuretic peptide and NTpro-BNP for monitoring therapy of heart failure: The role of biologic variation in the interpretation of results
    • Wu, A. H. Serial testing of B-type natriuretic peptide and NTpro-BNP for monitoring therapy of heart failure: The role of biologic variation in the interpretation of results. Am. Heart J. 152:828-834; 2006.
    • (2006) Am. Heart J , vol.152 , pp. 828-834
    • Wu, A.H.1
  • 55
    • 7044284668 scopus 로고    scopus 로고
    • High intraindividual variation of B-type natriuretic peptide (BNP) and amino-terminal proBNP in patients with stable chronic heart failure
    • Bruins, S.; Fokkema, M. R.; Romer, J. W.; Dejongste, M. J.; van der Dijs, F. P.; van den Ouweland, J. M.; Muskiet, F. A. High intraindividual variation of B-type natriuretic peptide (BNP) and amino-terminal proBNP in patients with stable chronic heart failure. Clin. Chem. 50:2052-2058; 2004.
    • (2004) Clin. Chem , vol.50 , pp. 2052-2058
    • Bruins, S.1    Fokkema, M.R.2    Romer, J.W.3    Dejongste, M.J.4    van der Dijs, F.P.5    van den Ouweland, J.M.6    Muskiet, F.A.7


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.